Artificial Intelligence Can Prevent a Delayed Diagnosis
Uday Rajaram recounts how an AI system pinpointed his mother's diabetes medication as the cause of diabetic ketoacidosis and acute pancreatitis within three minutes, delivering an 84% confidence rating. Traditional hospital diagnostics required six days, multiple specialists, and an ICU stay before the correct cause was identified. Rajaram then used AI to create a personalized nutrition and fitness plan, shedding 25 pounds and improving key health metrics. He argues that AI will not replace physicians but will become essential for faster, data‑driven decision‑making in medicine.
How Direct-to-Patient Is Redefining Drug Pricing
Jeremy Richardson, CCO of Gifthealth, argues that integrated direct‑to‑patient (DTP) models can overhaul the prescription journey by delivering transparent pricing, faster access, and reduced administrative friction. He highlights that 55% of Americans fear unaffordable drugs and that prior authorizations generate...
What Psychedelic Clinical Trials Could Teach Psychiatry
Treatment‑resistant depression (TRD) affects roughly one‑third of U.S. adults on antidepressants and remains a high‑need, low‑treatment area. Compass Pathways’ synthetic psilocybin, COMP360, recently achieved its primary endpoints in two Phase III trials—258 patients in COMP005 and 581 in COMP006—showing rapid, durable...
World AIDS Vaccine Day 2026: What HIV Vaccine Research Is Testing Now
World AIDS Vaccine Day 2026, themed “Rethink. Rebuild. Rise,” highlighted a shifting HIV prevention landscape. In Europe, funding for vaccine R&D fell from about $16.5 million in 2009 to roughly $9.9 million in 2020, jeopardizing expertise. New data show individual broadly neutralizing...
FDA’s New Pilot Program and Real-Time Review of Clinical Data
The FDA announced a pilot program that lets regulators review clinical trial data in real time, allowing safety signals and efficacy endpoints to be shared as they are recorded. Dr. Richard Graham explained that the initiative aims to eliminate the...
How Toragen's Alignment With The Gates Foundation Supports Global Access and Commercialization
Toragen announced a strategic partnership with the Bill & Melinda Gates Foundation to develop an oral small‑molecule therapy for cervical cancer. The collaboration builds on a 21‑year relationship that began through the Novartis Research Foundation and was accelerated by promising...
Alex Toohie | Meet the Speakers: Med-Tech Expo 2026
Alexander Toohie, Technical Solution Manager at Element Materials Technology, will speak at Med‑Tech Expo 2026 about mandatory approvals that sit outside the usual FDA and EU MDR pathways, especially the hidden classification of wireless medical devices as radio equipment. He...
The Rise and Fall of Safer Supply Programs in Canada
Safer supply programs, introduced in Canada in 2017, aimed to curb opioid overdose deaths by providing pharmaceutical‑grade alternatives to street drugs. By 2022, provincial roll‑outs spanned six provinces with roughly CAD 150 million (≈US 110 million) in federal funding, and early data showed a...
Student Demand Outpaces Campus Counseling Availability
TimelyCare’s new report, based on a survey of more than 130 campus counseling leaders, reveals that student mental‑health demand is outpacing the capacity of university counseling centers. Roughly 80% of respondents report staff‑to‑student ratios of 1:500 or higher, and 38%...
Healthcare ‘Quality’ Is Broken. Here’s How to Fix It.
Healthcare quality in the U.S. is widely perceived as poor, with 56% of Americans rating it fair or worse and 90% feeling they overpay. The article argues that the disconnect stems from industry‑centric metrics that ignore patient outcomes, experience, and...
Moderna Began Developing a Bundibugyo Ebola mRNA “Vaccine” Just 4 Months Before WHO Declared a Global Emergency
In January 2026, CEPI granted $26.7 million to Moderna and the University of Oxford to start mRNA and viral‑vector vaccine work against the Bundibugyo ebolavirus as part of a multivalent filovirus platform. Four months later, the WHO declared a Public Health...
What Contracting with Epic for an EHR License Really Involves: License Structure, Module Pricing, Affiliate Rights, Hosting, Termination Economics, and...
Epic’s EHR License and Support Agreement is widely regarded as the most one‑sided contract in healthcare IT. The agreement outlines a tiered license structure, per‑module pricing, strict affiliate rights, mandatory hosting on Epic’s cloud, and steep termination penalties. Because Epic...
Patient Involvement Transforms Modern Clinical Research
The article highlights a growing shift in clinical research from treating patients as passive subjects to engaging them as active partners. It distinguishes three levels—participation, engagement, and involvement—showing how deeper involvement lets patients shape study design and outcomes. The piece...
Wes Streeting, Palantir and the Corporate Capture of the NHS
Health Secretary Wes Streeting quit the cabinet and hinted at a leadership bid, while his resignation letter downplayed a controversial relationship with former Labour minister Peter Mandelson. Leaked WhatsApp exchanges show Mandelson advising Streeting on pharma policy and encouraging ties...
The Administrative Burden Crushing California Medicine
California’s health‑care system is being choked by administrative overload, with up to one‑quarter of spending—roughly $73 billion a year—going to paperwork, prior authorizations and managed‑care rules. Physicians now devote 14‑27% of their revenue to billing and insurance tasks, leading to burnout,...
Hospital Room Contamination Is a Prescribing Problem
Physician Franklyn Gergits recounts a 24‑year‑old trauma patient admitted to an ICU for observation, only to discover the room was contaminated with drug‑resistant bacteria from a prior patient. Despite rigorous hand‑washing and cleaning logs, surfaces like faucets and bed rails...
AI Clinical Judgment Is What AI Chatbots Still Lack
A Utah regulatory sandbox allowed an AI platform to renew prescriptions for roughly 200 chronic medications without a licensed clinician. A 72‑year‑old patient tested the system and found the chatbot could explain lab values but failed to ask about medications,...
Dr. Reddy’s Laboratories Launches Its Generic Semaglutide Injection in Canada
Dr. Reddy’s Laboratories received Health Canada’s Notice of Compliance on April 28, 2026 and launched the first generic semaglutide injection in Canada, the inaugural G7 approval for a generic version of the GLP‑1 drug. The product is offered in 2 mg and 4 mg...
ENHERTU® (Fam-Trastuzumab Deruxtecan-Nxki) Approved in the US for Two New Indications for Patients with HER2-Positive Early Breast Cancer
The FDA has approved AstraZeneca and Daiichi Sankyo’s ENHERTU (fam‑trastuzumab deruxtecan‑nxki) for both neoadjuvant and adjuvant treatment of HER2‑positive early‑stage breast cancer. In the neoadjuvant setting, ENHERTU plus taxane, trastuzumab and pertuzumab achieved a 67.3% pathologic complete response, outperforming standard...
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial
United Therapeutics received FDA clearance to begin the EXPRESS clinical trial of its UHeart xenotransplant, a pig‑derived heart with ten gene edits. The phase‑1/2/3 study will initially enroll up to two end‑stage heart‑failure patients, with safety and efficacy data reviewed...
Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer
Agenus published Phase 1b data on botensilimab plus balstilimab in 19 patients with treatment‑refractory hepatocellular carcinoma who had progressed after prior immunotherapy. The combination achieved a 17% objective response rate, a 50% clinical benefit rate at 18 weeks, median progression‑free survival...
TRI-611
TRI‑611 is a CNS‑penetrant, CRBN‑mediated molecular‑glue degrader targeting ALK fusion proteins in ALK‑positive non‑small cell lung cancer (NSCLC). By recruiting a non‑G‑loop degron distal to the orthosteric site, it degrades ALK independently of the active site, sidestepping common tyrosine‑kinase inhibitor...
Top 20 Fastest Growing Pharma & Biotech Companies in the Americas for 2026
The Financial Times‑Statista 2026 ranking spotlights the 20 fastest‑growing pharma and biotech firms in the Americas, measuring compound annual growth rates from 2021‑2024. Companies such as Capricor Therapeutics, BioAtla, Ardelyx, Legend Biotech and Repare Therapeutics posted explosive revenue gains, driven...
Marty Makary Steps Down as FDA Commissioner After Complaints, Adding to Regulatory Uncertainties
Marty Makary resigned as FDA commissioner after a turbulent 13‑month tenure marked by rapid regulatory experiments and political controversy. President Trump named deputy commissioner for food, Kyle Diamantas, a lawyer, as acting commissioner, placing a non‑physician at the agency’s helm. Makary’s...
Pharmaceutical Executive Daily: FDA Approves AstraZeneca's Fasenra
The FDA has approved AstraZeneca’s Fasenra (benralizumab) for patients 12 and older with hypereosinophilic syndrome (HES), adding a rare‑disease indication to a drug already used for severe eosinophilic asthma. The approval rests on the Phase III Natron trial, which showed a...
Medical Apology Laws Don’t Reduce Malpractice Lawsuits
Medical apology statutes, now in 39 states, DC and Guam, were intended to lower malpractice risk by letting clinicians express regret without legal penalty. Recent studies, however, show that apologies alone do not curb lawsuits and can even increase claims...
Independent Physicians Are Missing From Health Care Policy
A new federal Health Care Advisory Committee will shape Medicare, Medicaid and other programs, but it lacks any independent, private‑practice physicians. Independent doctors—about 250,000, or roughly one‑quarter of U.S. physicians—manage chronic illness daily and face steep administrative and payment challenges....
Organon to Present New Research on Access and Value at ISPOR 2026
Organon (NYSE: OGN) will showcase eight peer‑reviewed abstracts at ISPOR 2026, the premier health‑economics conference in Philadelphia. The presentations span cost‑effectiveness and budget‑impact analyses for its women’s health implant NEXPLANON in Brazil, the atopic dermatitis cream VTAMA from a U.S. Medicaid...
Why Corporate Medicine Fails Every Physician-Patient
Ronald L. Lindsay, a developmental‑behavioral pediatrician, argues that corporate medicine systematically fails physician‑patients because billing imperatives eclipse clinical judgment. He describes how his insider knowledge forces him to micromanage his own care, ration physical‑therapy visits, and anticipate delays that others...
GLP1 Access for Only a $50 Copay?
Medicare has unveiled a GLP‑1 Bridge program that begins on July 1, 2024 and runs through December 31, 2027. The initiative offers a flat $50 copayment for all four dosage tiers of GLP‑1 medicines, covering both injectable formulations and the new oral...
The Tragic Reality of Pregnancy-Associated Breast Cancer
Pregnancy‑associated breast cancer (PABC) affects roughly one in 3,000 pregnancies and is often a highly aggressive triple‑negative disease. The case of a 30‑year‑old mother who chose to keep her twins illustrates the clinical dilemma of balancing fetal safety with timely...
Women’s Health Investment: Rhetoric Vs. Reality
In a Pharmaceutical Executive interview, Toragen CEO Sandra Coufal argues that despite rising investor interest, funding for women‑specific treatments remains limited because total addressable market calculations rely on male‑biased trial data. This systemic under‑representation causes the commercial potential of women’s...
New Health Secretary Appointed – Will It Be Business as Usual?
James Murray, the former Chief Secretary to the Treasury, has been appointed Secretary of State for Health and Social Care. His tenure at the Treasury gives him intimate knowledge of the Department of Health and Social Care's budgets and reform...
Bethany Dean | Meet the Speakers: Med-Tech Expo 2026
Bethany Dean, a senior advisor at Taylored Consultancy, will present at Med‑Tech Expo 2026 on how companies can navigate products that sit between medical device, cosmetic, medicinal, and general‑product definitions. Her session promises practical methods to identify borderline classifications, real‑world...
As New Rules Take Hold, What Does ‘Good AI Practice’ Look Like in Drug Development?
On January 14 2026 the EMA and FDA published joint guiding principles that define good AI practice for drug development. The technology‑neutral framework emphasizes context of use, risk‑based controls, data governance, documentation and lifecycle management rather than adding new regulatory requirements. It...
How Big Health Brands Are Funding Online Medical Misinformation
A JAMA Network Open study by Yale researchers found that health‑related advertisers poured $35.7 million into 11 news sites flagged by NewsGuard for spreading false health information between 2021 and 2024. Overall ad spend on those sites reached $336 million, with major...
“We Deserve the Same Rights as Other Health Care Workers:” PSW Day Protest at Doug Ford’s Office on May 19
Personal support workers (PSWs) represented by CUPE are protesting Ontario’s Health and Supportive Care Oversight Authority (HSCPOA), which they say lacks due‑process safeguards and representation. The union plans a rally outside Premier Doug Ford’s Etobicoke office on May 19, 2026, marking PSW Day....
Court Allows for Access to Abortion Pill by Mail for Now
The U.S. Supreme Court issued an order on Thursday extending its pause on the 5th Circuit’s ruling that barred the mailing of mifepristone, the primary drug used in medication abortions. The stay keeps the abortion pill available by mail while the...
CDC’s Hantavirus Briefing Revealed a Public Health System Trying to Avoid Repeating 2020
The CDC held a 20‑minute briefing on the Andes hantavirus outbreak linked to a cruise ship, detailing a sizable response that includes more than 100 staff, deployments to the Canary Islands and Nebraska, and monitoring of exposed Americans. Officials emphasized...
World Clinical Trials Day 2026 Looks at the Science, Setbacks and Systems Behind New Medicines
World Clinical Trials Day 2026, observed on May 20, highlighted the “Research Rising” theme to honor the clinical‑research workforce and patients. Phase II studies now comprise 43% of the 584,000 active global trials, while oncology still drives 38% of Phase I‑III starts despite...
Transforming Clinical Trial Design and Avoiding AI Wrappers: Q&A with Angela Schwab
Trialynx CEO Angela Schwab explains how AI is reshaping clinical trial design by moving away from manual copy‑and‑paste protocols toward data‑driven, predictive modeling. AI can scan millions of past studies to suggest optimal endpoints, procedures, and patient pathways, reducing missed...
“Totally Unexpected” – Scientists Discover Pancreatic Cancer’s Fatal Addiction
Researchers at The Wistar Institute and ChristianaCare have uncovered a critical weakness in pancreatic cancer. They found that damaged mitochondria within tumor cells activate the TLR3‑TRAF6 signaling pathway, creating inflammation that the cancer depends on for growth. Blocking this pathway...
The Gender Pain Gap - More than 50% of Women Say Their Pain Is Ignored by Doctors
The Gender Pain Gap Index released by Nurofen reveals that over half of UK women feel their pain is dismissed by doctors, with the figure climbing to 73% among 18‑24‑year‑olds. Racial disparities are stark: 74% of Black women and 65%...
The Leaders Closing the Gap: How Strong Healthcare Administrators Are Driving Technology Transformation
Healthcare administrators are now the primary drivers of technology transformation, leveraging the operational lessons learned from decade‑long EHR deployments. Their expertise in budgeting, workflow redesign, and stakeholder alignment is enabling AI, integrated platforms, and advanced analytics to move from pilot...
Why Pharma Is Rethinking the Centralized Hub Model
Pharma companies are abandoning the legacy centralized hub model in favor of a tech‑enabled “hubless hub” that distributes access functions across digital platforms and specialized partners. The shift is driven by the growing complexity of specialty therapies, tighter payer requirements,...
Cyclarity Unveils Oxidized Cholesterol Excretion Data
Cyclarity Therapeutics presented Phase 1 data for UDP-003, its cyclodextrin drug that binds and removes oxidized cholesterol (7‑ketocholesterol) from humans. The Monash Victorian Heart Institute trial showed dose‑dependent urinary excretion of 7KC, with no serious adverse events and a short...
The ACCESS Model’s Behavioral Health Track
The CMS Innovation Center’s ACCESS Model launches on July 5 2026 with a behavioral health (BH) track that pays $180 per beneficiary in the Initial Period and $90 in the Follow‑On Period, contingent on meeting PHQ‑9 or GAD‑7 improvement thresholds. The track...
How Capital Costs Make It Near-Impossible to Be an Independent Physician
A new report highlights how soaring capital costs are pushing independent physicians out of business. Consolidation by hospital systems, insurers, and private‑equity firms has squeezed small practices, forcing them to seek expensive, often predatory financing. The analysis shows independent doctors...
Reducing No Shows at Regional Practices: How Automated Communications Help Connect Patients to Care
Patient no‑shows cost U.S. providers about $150 billion annually, with an 18 % national miss rate. Regional practices, lacking the scale of large systems, feel the revenue hit most acutely. Automated, two‑way communication platforms that deliver personalized reminders via text, call or...
CMS Announces Nationwide Crackdown on Fraud with Six-Month Hospice and Home Health Agency Enrollment Moratoria
The Centers for Medicare & Medicaid Services announced a six‑month, nationwide moratorium on new Medicare enrollment for hospice and home health agencies. The pause targets high‑risk fraud by blocking fresh providers and tightening ownership‑change approvals. During the moratorium CMS will...